Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6659b9f88f4eb2c7adc8137591282bc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2016-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acab65d924272b9829dd81093b904e4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a5cf4657b291e7e9e4fda70f799bc1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_303d51cd0482f66d3fd832ec97980fae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95d9e12b91853b61565d6405cac3c4dc |
publicationDate |
2017-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9834609-B2 |
titleOfInvention |
Methods of detecting a tumor expressing fibroblast growth factor receptor 2 |
abstract |
The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10689448-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172937-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447553-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11235059-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11091555-B2 |
priorityDate |
2008-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |